{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:32:31Z","timestamp":1770885151869,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-024-02563-x","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T14:08:52Z","timestamp":1732025332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of urinary function and prostate volume changes in localized prostate cancer patients treated with carbon-ion radiotherapy; a prospective study"],"prefix":"10.1186","volume":"19","author":[{"given":"Yoshiyuki","family":"Miyazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemasa","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Miyasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Kaminuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"2563_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4:877\u201392. https:\/\/doi.org\/10.1016\/j.euo.2021.09.006.","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"2563_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/iju.13593","volume":"25","author":"T Kimura","year":"2018","unstructured":"Kimura T, Egawa S. Epidemiology of prostate cancer in Asian countries. Int J Urol. 2018;25(6):524\u201331.","journal-title":"Int J Urol"},{"issue":"9","key":"2563_CR3","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","volume":"31","author":"C Parker","year":"2020","unstructured":"Parker C, Castro E, Fizazi K, Heidenreich A, Ost P, Procopio G, et al. ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(9):1119\u201334.","journal-title":"Ann Oncol"},{"key":"2563_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.ijrobp.2013.11.241","volume":"88","author":"D Georg","year":"2014","unstructured":"Georg D, Hopfgartner J, G\u00f2ra J, Kuess P, Kragl G, Berger D, et al. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2014;88:715\u201322.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2563_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0360-3016(02)02754-2","volume":"53","author":"H Paganetti","year":"2002","unstructured":"Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002;53(2):407\u201321.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"2563_CR6","first-page":"23","volume":"6","author":"KD Held","year":"2016","unstructured":"Held KD, Kawamura H, Kaminuma T, Paz AE, Yoshida Y, Liu Q, et al. Effects of Charged particles on human tumor cells. Front Oncol. 2016;6(Suppl 1):23.","journal-title":"Front Oncol"},{"key":"2563_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrclinonc.2017.30","volume":"14","author":"M Durante","year":"2017","unstructured":"Durante M, Orecchia R, Loeffler JS. Charged-particle therapy in cancer: clinical uses and future perspectives. Nat Rev Clin Oncol. 2017;14:483\u201395.","journal-title":"Nat Rev Clin Oncol"},{"key":"2563_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0360-3016(98)00544-6","volume":"44","author":"T Kanai","year":"1999","unstructured":"Kanai T, Endo M, Minohara S, Miyahara N, Koyama-ito H, Tomura H, et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:201\u201310.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2563_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1878-5085-4-9","volume":"4","author":"T Ohno","year":"2013","unstructured":"Ohno T. Particle radiotherapy with carbon ion beams. EPMA J. 2013;4(1):9.","journal-title":"EPMA J"},{"issue":"1","key":"2563_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12885-020-6570-8","volume":"20","author":"H Kawamura","year":"2020","unstructured":"Kawamura H, Kubo N, Sato H, Mizukami T, Katoh H, Ishikawa H, et al. Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study GUNMA0702. BMC Cancer. 2020;20(1):75.","journal-title":"BMC Cancer"},{"key":"2563_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1442-2042.2012.02961.x","volume":"19","author":"H Ishikawa","year":"2012","unstructured":"Ishikawa H, Tsuji H, Kamada T, Akakura K, Suzuki H, Shimazaki J, et al. Carbon-ion radiation therapy for prostate cancer. Int J Urol. 2012;19:296\u2013305.","journal-title":"Int J Urol"},{"issue":"10","key":"2563_CR12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1056\/NEJMp0911494","volume":"362","author":"E Basch","year":"2010","unstructured":"Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med. 2010;362(10):865\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"2563_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S0360-3016(02)02726-8","volume":"53","author":"C Choo","year":"2002","unstructured":"Choo C, Do R, Herschorn V, DeBoer S, Danjoux G, Morton C. Urodynamic changes at 18 months post-therapy in patients treated with external beam radiotherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys. 2002;53(2):290\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2563_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/pcan.2009.23","volume":"13","author":"V Tombolini","year":"2010","unstructured":"Tombolini V, Di Staso M, Bonfili P, Di Genesio Pagliuca M, Franzese P, et al. Subjective and objective measures of late genitourinary morbidity following hypofractionated radiotherapy in men with prostate cancer. Prostate Cancer Prostatic Dis. 2010;13(1):34\u20138.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"2563_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/jmrs.551","volume":"69","author":"T Iizumi","year":"2022","unstructured":"Iizumi T, Ishikawa H, Sekino Y, Tanaka K, Takizawa D, Makishima H, et al. Acute toxicity and patient-reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer. J Med Radiat Sci. 2022;69(2):198\u2013207.","journal-title":"J Med Radiat Sci"},{"issue":"2","key":"2563_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/jpm13020233","volume":"13","author":"P Milecki","year":"2023","unstructured":"Milecki P, Adamska A, Rucinska A, Pa\u0142ucki G, Szumi\u0142o A, Skroba\u0142a A, et al. Large prostate volume does not negatively Impact Health-Related Quality of Life in patients with prostate Cancer treated with Ultrahypofractionated Stereotactic Body Radiotherapy. J Pers Med. 2023;13(2):233.","journal-title":"J Pers Med"},{"issue":"6","key":"2563_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.rpor.2017.08.009","volume":"22","author":"H Tanaka","year":"2017","unstructured":"Tanaka H, Yamaguchi T, Hachiya K, Hayashi M, Ogawa S, Nishibori H, et al. Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone. Rep Pract Oncol Radiother. 2017;22(6):477\u201381.","journal-title":"Rep Pract Oncol Radiother"},{"issue":"2","key":"2563_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.urology.2008.12.062","volume":"74","author":"N Tanaka","year":"2009","unstructured":"Tanaka N, Fujimoto K, Hirao Y, Asakawa I, Hasegawa M, Konishi N. Variations in international prostate symptom scores, uroflowmetric parameters, and prostate volume after (125)I permanent brachytherapy for localized prostate cancer. Urology. 2009;74(2):407\u201311.","journal-title":"Urology"},{"issue":"16","key":"2563_CR19","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.3390\/cancers14164015","volume":"14","author":"Y Hiroshima","year":"2022","unstructured":"Hiroshima Y, Ishikawa H, Iwai Y, Wakatsuki M, Utsumi T, Suzuki H, et al. Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly patients with high-risk prostate Cancer. Cancers (Basel). 2022;14(16):4015.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2563_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/jjco\/hyad005","volume":"53","author":"T Takaoka","year":"2023","unstructured":"Takaoka T, Yanagi T, Tanaka A, Kiriyama Y, Tanaka Y, Kondo T, et al. Acute genitourinary toxicity of pencil beam scanning proton therapy for localized prostate cancer: utility of the transition zone index and average urinary flow rate in predicting acute urinary retention. Jpn J Clin Oncol. 2023;53(5):419\u201328.","journal-title":"Jpn J Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-024-02563-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-024-02563-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-024-02563-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T02:04:19Z","timestamp":1732068259000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-024-02563-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2563"],"URL":"https:\/\/doi.org\/10.1186\/s13014-024-02563-x","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"21 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study protocol was designed by the Working Group of Genitourinary Tumors of GHMC. The protocol was approved by the institutional ethical committee\u201d Gunma University Hospital Institutional Review Board\u201d, approval number 693, and was registered with the University Medical Information Network Clinical Trial Registry, number UMIN000003827. All patients signed informed consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable; Only aggregate data is published, and no patient identifying information is presented.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}